This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Hendricus Bartholomeus De Bont: Innovator in Cholesterol Management
Introduction
Hendricus Bartholomeus De Bont is a notable inventor based in the Netherlands. He has made significant contributions to the field of health and nutrition, particularly in the area of cholesterol management. His innovative approach focuses on developing effective solutions for lowering blood serum cholesterol levels.
Latest Patents
Hendricus Bartholomeus De Bont holds a patent for a Cholesterol Lowering Supplement. This invention provides a composition and a method for lowering blood serum cholesterol levels or preventing elevated blood serum cholesterol levels. The composition includes one or more phytosterols and/or phytostanols capable of reducing cholesterol absorption in the intestine, as well as soluble fibers that inhibit ileal bile acid absorption. Additionally, it features a composition that inhibits cholesterol biosynthesis and another that increases cholesterol metabolism, with at least one of these compositions preferably derived from plants.
Career Highlights
Hendricus Bartholomeus De Bont is currently associated with Pharmachem Laboratories, Inc. His work at this company emphasizes the importance of innovative health solutions. Despite having no patents attributed to him, his research and development efforts have contributed to advancements in dietary supplements.
Collaborations
Hendricus has collaborated with Qi Chen, enhancing the research and development process within his field. Their partnership reflects a commitment to innovation and improvement in health-related products.
Conclusion
Hendricus Bartholomeus De Bont is a dedicated inventor whose work in cholesterol management showcases the potential of innovative health solutions. His contributions to the field are significant, and his ongoing efforts continue to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile